Clik here to view.
Mapping Which Coronavirus Variants Will Resist Antibody Treatments
Caption: The antibody LY-CoV016 (purple) is bound to RBD. This “escape map” indicates where in the viral RBD new mutations are most likely to make LY-CoV016 less effective (red). It also shows places...
View ArticleClik here to view.
South Africa Study Shows Power of Genomic Surveillance Amid COVID-19 Pandemic
Credit: iStock/Thomas Faull Considerable research is underway around the world to monitor the spread of new variants of SARS-CoV-2, the coronavirus that causes COVID-19. That includes the variant...
View ArticleClik here to view.
Infections with ‘U.K Variant’ B.1.1.7 Have Greater Risk of Mortality
Since the genome sequence of SARS-CoV-2, the virus responsible for COVID-19, was first reported in January 2020, thousands of variants have been reported. In the vast majority of cases, these...
View ArticleClik here to view.
Tracking the Evolution of a ‘Variant of Concern’ in Brazil
By last October, about three out of every four residents of Manaus, Brazil already had been infected with SARS-CoV-2, the virus that causes COVID-19 [1]. And yet, despite hopes of achieving “herd...
View ArticleClik here to view.
A Real-World Look at COVID-19 Vaccines Versus New Variants
Credit: Getty Images/Andrey Popov Clinical trials have shown the COVID-19 vaccines now being administered around the country are highly effective in protecting fully vaccinated individuals from the...
View ArticleClik here to view.
Could a Nasal Spray of Designer Antibodies Help to Beat COVID-19?
There are now several monoclonal antibodies, identical copies of a therapeutic antibody produced in large numbers, that are authorized for the treatment of COVID-19. But in the ongoing effort to beat...
View Article
